Allergan has agreed to sell Zenpep pancrelipase to Nestle and return Crohn's disease candidate brazikumab to AstraZeneca as part of ongoing regulatory reviews of AbbVies planned $63 billion acquisition of Allergan.The post Allergan Sells Zenpep Brazikumab...
↧